Corbus Pharmaceuticals
CRBP
$38.77
Share price
1.49%
Change (1 day)
268.89%
Change (1 year)
Categories
Corbus Pharmaceuticals (CRBP) - P/B ratio
P/B ratio as of May 2024 : -59.0
According to Corbus Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of -59.0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Corbus Pharmaceuticals - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -3.87 | -1022.17% |
| 2022-12-31 | 0.4196 | -62.39% |
| 2021-12-31 | 1.12 | -51.91% |
| 2020-12-31 | 2.32 | -95.95% |
| 2019-12-31 | 57.3 | 372.12% |
| 2018-12-31 | 12.1 | 77.89% |
| 2017-12-31 | 6.83 | -83.78% |
| 2016-12-31 | 42.1 | 509.63% |
| 2015-12-31 | 6.91 | -47.8% |
| 2014-12-31 | 13.2 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Viking Therapeutics
VKTX | 9.09 | -115.40% | 🇺🇸 USA |
 Vanda Pharmaceuticals VNDA | 0.5212 | -100.88% | 🇺🇸 USA |
 Advaxis ADXS | -0.9682 | -98.36% | 🇺🇸 USA |